LDHA-mediated CREB1 Lactylation Promotes Breast Cancer Brain Metastasis by Transcriptionally Activating Cytoskeletal Remodeling

Clicks: 1
ID: 314595
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #111 of 126 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 126 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Brain metastasis (BM) is a leading cause of mortality in breast cancer patients. This study utilizes single-cell RNA sequencing (scRNA-seq) to identify high-risk malignant sub-clusters and uncover potential therapeutic targets driving BM. Methods Five pairs of scRNA-seq data of primary breast tumors (PT) and brain metastases (BM) were retrieved from the Gene Expression Omnibus (GEO) database. Following unsupervised clustering and cell-type annotation, specialized bioinformatic pipelines—including inferCNV and pseudotime trajectory analysis—were implemented to delineate malignant subpopulations and evolutionary states associated with high brain metastatic potential. Molecular mechanisms were investigated using ChIP-qPCR, nascent RNA labeling assay, and dual-luciferase assays. Clinical significance was evaluated in a 124 paired-patient cohort using propensity score matching (PSM), while in vivo metastatic potential was assessed via a murine carotid artery injection model. Results We identified a specific malignant epithelial sub-cluster (Cluster 3) characterized by high lactate levels and superior BM potential, and subsequently establishing CREB1 lactylation as a biomarker of this cluster. Mechanistically, LDHA-mediated lactylation of CREB1 at Lysine 136 (K136) enhances its transcriptional activity, upregulating cytoskeletal genes including CALML5, CNN2, and PDLIM1. This axis facilitates pseudopodia formation, cellular migration. In vivo, LDHA knockdown significantly reduced intracranial tumor burden. Clinically, high lactylation scores and high CALML5 expression are independent predictors of brain metastasis and overall survival. Conclusions The LDHA-lactylation-CREB1-cytoskeleton axis is a novel driver of brain metastasis, serving as a promising therapeutic target and prognostic biomarker for breast cancer.
Reference Key
openalex_W7161984817 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Siqi Liu, Zhirui Bai, Yifan Qiao, Yihan Ge, Fengyi Qu, M H Li, Yì Wáng, Xiaobo Shi, Yuan Ma, Jing Li, Xuhuan Cao, Feng Guo, Xi Zhang, Yuchen Sun
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag114
URL
https://doi.org/10.1093/neuonc/noag114
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.